More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene
Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds
ASTRO Issues Statement On APBI For Breast Cancer
Denosumab Demonstrates Superiority Over Zometa For Bone Metastases
Lymphedema Education Helps Reduce Symptoms, Study Finds
Exercise May Help Combat Leukemia Patients’ Fatigue
Cranial Radiation Eliminated With Personalized Chemo
Young Early-Stage Patients Can Preserve Fertility
Limb-Sparing Surgery May Not Offer Better Quality of Life
AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows
Budesonide Not Beneficial For Diarrhea In Melanoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
